REPORT ID 1040

China Stem Cell Therapy Market Research Report 2017

Publish Date
04-Dec-17
Pages
113
Format
Electronic (PDF)

The global Stem Cell Therapy market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Stem Cell Therapy development status and future trend in China, focuses on top players in China, also splits Stem Cell Therapy by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
    Cellular Dynamics International
    Osiris Therapeutics
    Vcanbio
    Gamida Cell
    Golden Meditech
    Celgene
    Guanhao Biotech
    Mesoblast
    Vericel Corporation
    Stemcell Technologes
    Beike Biotechnology
    Cytori Therapeutics
    Bioheart
    Pluristem Therapeutics
    Fibrocell Science
    Ocata Therapeutics
    Athersys
    Geron

Geographically, this report splits the China market into six regions,
    South China
    East China
    Southwest China
    Northeast China
    North China
    Central China
    Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Autologous
    Allogeneic

On the basis of the end users/application, this report covers
    CNS
    CVS
    GIT
    Wounds and Injuries
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

China Stem Cell Therapy Market Research Report 2017
1 Stem Cell Therapy Overview
    1.1 Product Overview and Scope of Stem Cell Therapy
    1.2 Classification of Stem Cell Therapy by Product Category
        1.2.1 China Stem Cell Therapy Sales (K Units) Comparison by Type (2012-2022)
        1.2.2 China Stem Cell Therapy Sales (K Units) Market Share by Type in 2016
        1.2.3 Autologous
        1.2.4 Allogeneic
    1.3 China Stem Cell Therapy Market by Application/End Users
        1.3.1 China Stem Cell Therapy Sales (K Units) and Market Share Comparison by Applications (2012-2022)
        1.3.2 CNS
        1.3.3 CVS
        1.3.4 GIT
        1.3.5 Wounds and Injuries
        1.3.6 Others
    1.4 China Stem Cell Therapy Market by Region
        1.4.1 China Stem Cell Therapy Market Size (Million USD) Comparison by Region (2012-2022)
        1.4.2 South China Stem Cell Therapy Status and Prospect (2012-2022)
        1.4.3 East China Stem Cell Therapy Status and Prospect (2012-2022)
        1.4.4 Southwest China Stem Cell Therapy Status and Prospect (2012-2022)
        1.4.5 Northeast China Stem Cell Therapy Status and Prospect (2012-2022)
        1.4.6 North China Stem Cell Therapy Status and Prospect (2012-2022)
        1.4.7 Central China Stem Cell Therapy Status and Prospect (2012-2022)
    1.5 China Market Size (Sales and Revenue) of Stem Cell Therapy (2012-2022)
        1.5.1 China Stem Cell Therapy Sales (K Units) and Growth Rate (%)(2012-2022)
        1.5.2 China Stem Cell Therapy Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Stem Cell Therapy Market Competition by Players/Manufacturers
    2.1 China Stem Cell Therapy Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.2 China Stem Cell Therapy Revenue and Share by Players/Manufacturers (2012-2017)
    2.3 China Stem Cell Therapy Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
    2.4 China Stem Cell Therapy Market Competitive Situation and Trends
        2.4.1 China Stem Cell Therapy Market Concentration Rate
        2.4.2 China Stem Cell Therapy Market Share of Top 3 and Top 5 Players/Manufacturers
        2.4.3 Mergers & Acquisitions, Expansion in China Market
    2.5 China Players/Manufacturers Stem Cell Therapy Manufacturing Base Distribution, Sales Area, Product Types

3 China Stem Cell Therapy Sales and Revenue by Region (2012-2017)
    3.1 China Stem Cell Therapy Sales (K Units) and Market Share by Region (2012-2017)
    3.2 China Stem Cell Therapy Revenue (Million USD) and Market Share by Region (2012-2017)
    3.3 China Stem Cell Therapy Price (USD/Unit) by Regions (2012-2017)

4 China "&B1&" Sales and Revenue by Type/ Product Category (2012-2017)"
    4.1 China Stem Cell Therapy Sales (K Units) and Market Share by Type/ Product Category (2012-2017)
    4.2 China Stem Cell Therapy Revenue (Million USD) and Market Share by Type (2012-2017)
    4.3 China Stem Cell Therapy Price (USD/Unit) by Type (2012-2017)
    4.4 China Stem Cell Therapy Sales Growth Rate (%) by Type (2012-2017)

5 China "&B1&" Sales by Application (2012-2017)"
    5.1 China Stem Cell Therapy Sales (K Units) and Market Share by Application (2012-2017)
    5.2 China Stem Cell Therapy Sales Growth Rate (%) by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6 China Stem Cell Therapy Players/Suppliers Profiles and Sales Data
    6.1 Cellular Dynamics International
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Stem Cell Therapy Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Cellular Dynamics International Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Osiris Therapeutics
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Stem Cell Therapy Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Osiris Therapeutics Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Vcanbio
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Stem Cell Therapy Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Vcanbio Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Gamida Cell
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Stem Cell Therapy Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Gamida Cell Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Golden Meditech
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Stem Cell Therapy Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Golden Meditech Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Celgene
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Stem Cell Therapy Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Celgene Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Guanhao Biotech
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Stem Cell Therapy Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Guanhao Biotech Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Mesoblast
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Stem Cell Therapy Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Mesoblast Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Vericel Corporation
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Stem Cell Therapy Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Vericel Corporation Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Stemcell Technologes
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Stem Cell Therapy Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Stemcell Technologes Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Beike Biotechnology
    6.12 Cytori Therapeutics
    6.13 Bioheart
    6.14 Pluristem Therapeutics
    6.15 Fibrocell Science
    6.16 Ocata Therapeutics
    6.17 Athersys
    6.18 Geron

7 Stem Cell Therapy Manufacturing Cost Analysis
    7.1 Stem Cell Therapy Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Stem Cell Therapy

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Stem Cell Therapy Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Stem Cell Therapy Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 China Stem Cell Therapy Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 China Stem Cell Therapy Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
    11.2 China Stem Cell Therapy Sales (K Units) Forecast by Type (2017-2022)
    11.3 China Stem Cell Therapy Sales (K Units) Forecast by Application (2017-2022)
    11.4 China Stem Cell Therapy Sales (K Units) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
    13.4 Author List